Sharp Corona virus test certificate

Research Proves for First Time Ever That Sharp’s Plasmacluster Technology Inhibits Airborne Avian Influenza A (H7N9) Virus

For First Time Ever, Plasmacluster Ions Shown to Inhibit Infectivity of New-Type H1N1 Influenza Virus in Both Stationary and Airborne Form

Verification Research Conducted Jointly with the Kitasato Institute

Sharp’s High-Density Plasmacluster Ions Proven Effective on Human Skin in Controlling Staphylococcus Aureus, a Cause of Rough Skin, and in Curbing Excess Sebum, a Cause of Undesirable Oily Surface Shine on the Skin

Sharp Confirms Three Skin Beautifying Effects from Water Molecule Coating – Preserves Skin Moisture as Well as Improves Skin Elasticity and Texture

Sharp’s High-Density Plasmacluster Ions 1 (25,000 ions/cm3) Proven Effective in Preserving Skin Moisture

Sharp Proves Ability of High-Density Plasmacluster Ions to Eliminate (in a 1-m3 box) Airborne Bacteria and Odors, as well as Inhibit Infectivity of Canine Parvovirus in an Animal Hospital

Sharp announced that its exclusive Plasmacluster1 Air Purification Technology is proven effective against the New-type H1N1 SWINE Influenza virus (reduced by 99.9%)

Plasmacluster Ion Technology Shown to Promote Hair Growth by Improving Barrier Function of Scalp (Improving Scalp Environment)

Plasmacluster Ion Technology Shown to Promote Hair Growth by Improving Barrier Function of Scalp (Improving Scalp Environment)

Plasmacluster Technology Proven to Decrease Risk of Tuberculosis Infection in Tuberculosis Hospital for the First Time

In an investigator initiated clinical trial, Plasmacluster Ion technology reduced airway inflammation in pediatric patients with mild to moderate atopic asthma

World’s First Verification by Clinical Trial of the Effectiveness of High-Density Plasmacluster Ions
in Decreasing the Rate of Influenza Virus Infection

Plasmacluster Technology Shown Effective in Controlling Effects of Bacteria and Fungi Adhering to Yellow Sand and in Removing Organic Chemicals Contained in PM2.5

Sharp’s Plasmacluster Technology Proven Effective in Inhibiting the Activity of Adherent and Airborne Methicillin-Resistant Staphylococcus Aureus (MRSA), a Typical Bacterial Cause of Hospital-Acquired Infections

Joint Research with Hiroshima University Proves Plasmacluster Technology Suppresses Effects of Airborne Fungi Allergens

Joint Research with Osaka City University Medical School Validates Inhibitory Effects of Sharp’s High-Density Plasmacluster Ions on Allergic Reactions

Plasmacluster Technology Proven to Decrease Risk of Tuberculosis Infection in Tuberculosis Hospital for the First Time